Detalles de la búsqueda
1.
Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK.
Int J Chron Obstruct Pulmon Dis
; 13: 2707-2720, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30214188
Resultados
1 -
1
de 1
1
Próxima >
>>